Gastrointestinal endocrine tumors: Recent developments

Endocrine Pathology

Volumn 9, Issue 2, 1998, Pages 99-115

  Bordi, Cesare ^a   D'Adda, Tiziana ^b   Azzoni, Cinzia ^b   Canavese, Gabriella ^b   Brandi, Maria Luisa ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b NONE

Author keywords

BCL ; Carcinoid tumors; ECL cell; Gastrinomas; Growth factors; Host responses to tumors; MEN 1 gene; MEN 1 syndrome; subunit of human chorionic gonadotropin

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CHORIONIC GONADOTROPIN; GASTRIN; GROWTH FACTOR; NERVE GROWTH FACTOR; PROTEIN BCL 2; SOMATOMEDIN B; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

APPENDIX TUMOR; CARCINOID; DUODENUM TUMOR; ENDOCRINE TUMOR; GASTRINOMA; GASTROINTESTINAL TUMOR; GENE EXPRESSION; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RECTUM TUMOR; REVIEW; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0031872446     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02782603     Document Type: Review

References (72)

1. Solcia E, Fiocca R, Rindi G, Villani L, Cornaggia M, Capella C. The pathology of the gastrointestinal endocrine system. Endocrinol Metab Clin North Am 22:795-821, 1993.
2. Dayal Y. Endocrine pathology of the gut and pancreas. Boca Raton: CRC, 1991.
3. Solcia E, Rindi G, Sessa F, Fiocca R, Luinetti O, Bosi F. Endocrine tumours of the gastrointestinal tract. In: Polak JM, ed. Diagnostic histopathology of neuroendocrine tumours. Edinburgh: Churchill Livingstone, 1993; 123-149.
4. Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425:547-560, 1995.
5. Solcia E, Rindi G, Fiocca R, Villani L, Buffa R, Ambrosiani L, et al. Distinct patterns of chronic gastritis associated with carcinoid, neuroendocrine carcinoma or ordinary cancer and their role in tumorigenesis. Yale J Biol Med 65:793-804, 1992.
6. Bordi C, D'Adda T, Azzoni C, Pilato FP, Caruana P. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 19 (Suppl 1):S8-S19, 1995.
7. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology and behavior. Clinicopathologic analysis of 205 cases. World J Surg 20:158-172, 1996.
8. Bordi C, Falchetti A, Azzoni C, D'Adda T, Canavese G, Guariglia A, et al. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol 21:1075-1082, 1997.
9. Bordi C. Endocrine tumours of the stomach. Pathol Res Pract 191:373-380, 1995.
10. Pipeleers-Marichal M, Somers G, Willems G, Foulis A, Imrie C, Bishop AE, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 322:723-727, 1990.
11. Lundqvist M, Wilander E. A study of the histopathogenesis of carcinoid tumors of the small intestine and appendix. Cancer 60:201-206, 1987.
12. Fiocca R, Rindi G, Capella C, Grimelius L, Polak JM, Yanaihara N, et al. Glucagon, glicentin, proglucagon, PYY, PP and pro-PP-icosapeptide immunoreactivities of rectal carcinoid tumours and related nontumour cells. Regul Pept 29:9-29, 1987.
13. Brandi ML, Bordi C, Falchetti A, Tonelli F, Marx SJ. Multiple endocrine neoplasia type 1. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. San Diego: Academic, 1996; 783-797.
14. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87, 1988.
15. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-rype 1. Science 276:404-407, 1997.
16. Lubensky IA, Debelenko LV, Zhuang ZP, Emmert-Buck MR, Dong Q, Chandrasekharappa SC, et al. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 56:5272-5278, 1996.
17. Cadiot G, Laurent-Puig P, Thuille B, Lehy T, Mignon M, Olschwang S. Is the multiple endocrine neoplasia type-1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology 105:579-582, 1993.
18. Beckers A, Abs R, Reyniers E, De Boulle K, Stevenaert A, Heller FR, et al. Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndrome. J Clin Endocrinol Metab 79:1498-1502, 1994.
19. Debelenko LV, Emmert-Buck MR, Zhuang ZP, Epshteyn E, Moskaluk CA, Jensen RT, et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 113:773-781, 1997.
20. Bordi C, D'Adda T, Azzoni C, Ferraro G. Pathogenesis of ECL cell tumors in humans. Yale J Biol Med 1997, in press.
21. Debelenko LV, Zhuang ZP, Emmert-Buck MR, Chandrasekharappa SC, Manickam P, Guru SC, et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 57:2238-2243, 1997.
22. Jakobovitz O, Nass D, De Marco L, Barbosa AJA, Simoni FB, Rechavi G, et al. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab 81:3164-3167, 1996.
23. Lohmann DR, Funk A, Niedermeyer HP, Haupel S, Höfler H. Identification of p53-gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA. Virchows Arch [B] 64:293-296, 1993.
24. Weckstrom P, Hedrum A, Makridis C, Akerstrom G, Rastad J, Scheibenpflug L, et al. Midgut carcinoids and solid carcinomas of the intestine: Differences in endocrine markers and p53 mutations. Endocr Pathol 7:273-279, 1996.
25. Younes N, Fulton N, Tanaka R, Wayne J, Straus FH, Kaplan EL. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Cancer 79:1804-1808, 1997.
26. Vortmeyer AO, Lubensky IA, Merino MJ, Wang CY, Pham T, Furth EE, et al. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst 89:1448-1453, 1997.
27. Puetzal L, Lewis CE, Lorenzen J, McGee OD. Growth factors: regulation of normal and neoplastic growth. J Parhol 169:191-201, 1993.
28. Lloyd RV. Growth factors. Endocr Pathol 8:121-127, 1997.
29. Lester WM, Godieb AI. The cardiovascular system. In: Kovacs K, Asa SL, eds. Functional endocrine pathology, voL 2. Boston: Blackwell, 1991; 724-747.
30. Moertel CG, Sauer WG, Dockerty MB, Baggenstoss AH. Life history of die carcinoid tumor of die small intestine. Cancer 14:901-912, 1961.
31. McNeal JE. Mechanism of obstruction in carcinoid tumors of the small intestine. Am J Clin Pathol 56:454-458, 1971.
32. Anthony PP, Drury RAB. Elastic vascular elastosis of mesenteric blood vessels in argentaffin carcinoma. J Clin Pathol 23:110-118, 1970.
33. Qizilbash AH. Carcinoid tumors, vascular elastosis, and ischemic disease of the small intestine. Dis Col Rect 20:554-560, 1977.
34. Harvey JN, Denyer ME, DaCosta P. Intestinal infarction caused by carcinoid associated elastic vascular sclerosis: early presentation of a small ileal carcinoid tumour. Gut 30:691-694, 1989.
35. Cai YC, Barnard G, Hiestand L, Woda B, Colby J, Banner B. Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor-alpha. Am J Surg Pathol 21:1373-1377, 1997.
36. Bordi C, Caruana P, D'Adda T, Azzoni C. Smooth muscle cell abnormalities associated with gastric ECL cell carcinoids. Endocr Pathol 6:103-113, 1995.
37. Caruana P, Azzoni C, Bertelé A, Annibale B, Franzé A, Delle Fave G, et al. Focal oxyntic gland atrophy with endocrine cell hyperplasia in Zollinger-Ellison syndrome during omeprazole treatment. Histopathology 21:359-363, 1992.
38. Roncoroni L, Costi R, Canavese G, Violi V, Bordi C. Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding. Am J Gastroenterol 92: 2119-2121, 1997.
39. Masson P. Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa. Am J Pathol 4:181-211, 1928.
40. Olsen BS, Holck S. Neurogenous hyperplasia leading to appendiceal obliteration: an immunohistochemical study of 237 cases. Histopathology 11:843-849, 1987.
41. Beauchamp RD, Coffey RJ, Lyons RM, Perkett EA, Townsend CM, Moses HL. Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth. Cancer Res 51:5253-5260, 1991.
42. Nilsson O, Wängberg B, Kölby L, Schultz GS, Ahlman H. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours. Int J Cancer 60:645-651, 1995.
43. Krishnamurthy S, Dayal Y. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids. Am J Surg Pathol 21:327-333, 1997.
44. Chaudhry A, Öberg K, Gobi A, Heldin C-H, Funa K. Expression of transforming growth factors β1, β2, β3 in neuroendocrine tumors of the digestive system. Anticancer Res 14:2085-2091, 1994.
45. Ahlman H, Wangberg B, Nilsson O. Growth regulation in carcinoid tumors. Endocrinol Metab Clin North Am 22:889-915, 1993.
46. Waltenberger J, Lundin L, Öberg K, Wilander E, Miyazono K, Heldin C-H, et al. Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 142:71-78, 1993.
47. Nilsson O, Wangberg B, Mcrae A, Dahlstrom A, Ahlman H. Growth factors and carcinoid tumours. Acta Oncol 32:115-124, 1993.
48. Chaudhry A, Papanicolau V, Öberg K, Heldin C-H, Funa K. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system. Cancer Res 52:1006-1012, 1992.
49. Goldfarb M. The fibroblast growth factor family. Cell Growth Diff 1:439-445, 1990.
50. Unsicker K, Reichert-Preibish H, Schmidt R, Pettman B, Labourdette G, Sensenbrenner M. Astroglial and fibroblast growth factors have neurotrophic functions for cultured peripheral and central nervous system neurons. Cell Tissue Res 84:5459-5463, 1987.
51. Wanaka A, Johnson EM, Milbrandt J. Localization of aFGF receptor mRNA in the adult rat central nervous system neurons by in situ hybridization. Neuron 5:267-281, 1990.
52. Zimering MB, Katsumata N, Sato Y, Brandi ML, Aurbach GD, Marx SJ, et al. Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type-1 - relation to pituitary tumor. J Clin Endocrinol Metab 76:1182-1187, 1993.
53. Brandi ML, Aurbach GD, Fitzpatrick LA, Quarto R, Spiegel AM, Bliziotes MM, et al. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med 314:1287-1293, 1986.
54. La Rosa S, Chiaravalli AM, Capella C, Uccella S, Sessa F. Immunohistochemical localization of acidic fibroblast growth factor in normal human enterochromaffin cells and related gastrointestinal tumours. Virchows Arch 430:117-124, 1997.
55. Bordi C, Falchetti A, Buffa R, Azzoni C, D'Adda T, Caruana P, et al. Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin. Hum Pathol 25:175-180, 1994.
56. Chaudhry A, Funa K, Öberg K. Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system. Acta Oncol 32:107-114, 1993.
57. Hanneken A, Baird A. Immunolocalization of basic fibroblast growth factor - dependence on antibody type and tissue fixation. Exp Eye Res 54:1011-1014, 1992.
58. Nilsson O, Dahlström A, Grönstad K-O, Rosengren L, Briving C, Skolnik G, et al. Successful transplantation of a human midgut carcinoid tumour to the anterior eye chamber of the rat. Acta Physiol Scand 120:317-319, 1984.
59. Theodorsson E, Ryberg B, Nilsson O, Ericson LE, Dahlström A, Ahlman H. Intraocular transplants of a human gastrinoma in immunosuppressed rats: morphological, chromatographic and functional studies. Regul Pept 24:97-110, 1989.
60. Wigander A, Lundmark K, McRae A, Mölne J, Nilsson O, Haglid K, et al. Production of transferable neuronotrophic factor(s) by human midgut carcinoid tumour cells; studies using cultures of rat fetal cholinergic neurons. Acta Physiol Scand 141:107-117, 1991.
61. Solcia E, Bordi C, Creutzfeldt W, Dayal Y, Dayan AD, Falkmer S, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 41:185-200, 1988.
62. Tang LH, Modlin IM, Lawton GP, Kidd M, Chinery R. The role of transforming growth factor alpha in the enterochromaffin-like cell tumor autonomy in an African rodent mastomys. Gastroenterology 111:1212-1223, 1996.
63. Håkanson R, Sundler F. The gastrin concept: the proposed mechanism behind the development of drug-induced gastric carcinoids. In: Håkanson R, Sundler F, eds. The stomach as an endocrine organ. Amsterdam: Elsevier, 1991; 449-460.
64. Carlsson E, Havu N, Mattsson H, Ekman L, Ryberg B. Gastric carcinoids in rats treated with inhibitors of gastric acid secretion. In: Håkanson R, Sundler F, eds. The stomach as an endocrine organ. Amsterdam: Elsevier, 1991; 461-471.
65. Håkanson R, Ekelund M, Sundler F. Activation and proliferation of gastric endocrine cells. In: Falkmer S, Håkanson R, Sundler F, eds. Evolution and tumor pathology of the neuroendocrine system. Amsterdam: Elsevier, 1984; 371-398.
66. Håkanson R, Tielemans Y, Chen D, Andersson K, Mattsson H, Sundler F. Time-dependent changes in enterochromaffinlike cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 105:15-21, 1993.
67. Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 102:1409-1418, 1992.
68. Bordi C, Azzoni C, D'Adda T, Bertelé A, Volpi R, Franzè A. Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? Endocr Pathol 6:345-354, 1995.
69. Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opinion Oncol 7:541-546, 1995.
70. Azzoni C, Doglioni C, Viale G, Delle Fave G, Deboni M, Caruana P, et al. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. Am J Surg Pathol 20:433-441, 1996.
71. Bordi C, Pilato FP, Bertelé A, D'Adda T, Missale G. Expression of glycoprotein hormone alpha-subunit by endocrine cells of the oxyntic mucosa is associated with hypergastrinemia. Hum Pathol 19:580-585, 1988.
72. Heitz PU, Kasper M, Klöppel G, Polak JM, Vaitukaitis JL. Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: a specific marker for malignancy. Immunocytochemical analysis of tumors of 155 patients. Cancer 51:277-282, 1983.